UK pharma major AstraZeneca on Friday announced an agreement with US President Donald Trump’s administration to lower the ...

South Korea-based Celltrion on Friday announced that the US Food and Drug Administration (FDA) has approved Eydenzelt ...

US pharma major Bristol Myers Squibb has entered into a definitive agreement to acquire Orbital Therapeutics, a privately ...

US biotech major Biogen and RNA medicine specialist Stoke Therapeutics have presented longer-term follow-up analyses from the ...

German pharma major Bayer’s gene therapy subsidiary AskBio today announced initial safety data from the first cohort of ...

Spanish plasma-based medicines producer Grifols announced that Yimmugo, an innovative intravenous immunoglobulin (IVIg) ...

Swedish oncology specialist Xspray Pharma has received a complete response letter (CRL) from the US Food and Drug ...

UK pharma major AstraZeneca announced that it will now invest $4.5 billion in its new manufacturing facility in Virginia, a ...

An Expert View from Agnese Cattaneo, Chief Medical Officer at Angelini Pharma.

India-headquartered Lupin has announced its plans for a new state-of-the-art pharmaceutical manufacturing plant in Coral ...

Expedition Therapeutics has closed a $165 million series A financing, just two months after acquiring global rights outside ...

US venture firm Ascenta Capital has closed its inaugural fund at $325 million, marking a significant milestone two years ...